🔴 Oncolytics Biotech is trading 7.4% down — no clear company-specific catalyst

Oncolytics Biotech is trading at $0.45, down 7.37%, with no clear company-specific news explaining the decline.

• Price was reported at 9:47 a.m. Eastern on October 14, 2026.
• A pelareorep patent announcement was reported October 13, but coverage does not establish it as the cause of the decline.
• XBI is down 2.01%; broader index moves are mixed and modest. No trading-volume data was provided.